Denise Dignam
President & CEO at The Chemours Company
Sits on 2 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Kulicke and Soffa Industries Inc., 3 years.
Kulicke and Soffa Industries Inc.
Director
The Chemours Company
Director · Chief Executive Officer
Chief executive roles
The Chemours Company
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 11, 2026 | The Chemours Company | Open-market purchase | +3,378 | $14.95 | $50,501 |
| Aug 1, 2026 | The Chemours Company | Shares withheld for tax | −477 | $16.61 | $7,923 |
| Jul 6, 2026 | Kulicke and Soffa Industries Inc. | Grant or award | +407 | — | — |
| Apr 6, 2026 | Kulicke and Soffa Industries Inc. | Grant or award | +675 | — | — |
| Mar 2, 2026 | The Chemours Company | Grant or award | +169,538 | — | — |
| Mar 1, 2026 | The Chemours Company | Shares withheld for tax | −22,220 | $18.24 | $405,293 |
| Feb 24, 2026 | The Chemours Company | Grant or award | +2,261 | — | — |
| Feb 24, 2026 | The Chemours Company | Shares withheld for tax | −742 | $18.41 | $13,660 |
| Jan 5, 2026 | Kulicke and Soffa Industries Inc. | Grant or award | +876 | — | — |
| Oct 6, 2025 | Kulicke and Soffa Industries Inc. | Grant or award | +1,081 | — | — |
| Aug 8, 2025 | The Chemours Company | Open-market purchase | +4,068 | $12.06 | $49,060 |
| Aug 1, 2025 | The Chemours Company | Shares withheld for tax | −466 | $11.50 | $5,359 |
| Jul 1, 2025 | Kulicke and Soffa Industries Inc. | Grant or award | +1,260 | — | — |
| Apr 1, 2025 | Kulicke and Soffa Industries Inc. | Grant or award | +1,343 | — | — |
| Mar 3, 2025 | The Chemours Company | Grant or award | +106,421 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.